Company Sector
Gene Therapy
Gene Therapy includes companies delivering genetic material to correct, replace, silence, or modulate disease-driving biology. This sector page is useful for following businesses exposed to AAV, lentiviral, non-viral, or editing-enabled approaches across rare and broader diseases.
Why watch Gene Therapy
This page combines a company index, a watch action, and the newest relevant feed items in one place so readers can monitor a biotech theme without scanning each company one by one.
Latest Gene Therapy news
The latest feed items from companies currently grouped under Gene Therapy.
- 01
- 02
- 03
- 04
- 05
GSKRoy Jakobs to join GSK Board as Non-Executive Director
Source: GSK plc
- 06
CRNXVertex to Acquire Crinetics Pharmaceuticals | Crinetics
Source: Crinetics Pharmaceuticals
- 07
BCRXBioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: BioCryst Pharmaceuticals
- 08
- 09
ABEOAbeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Abeona Therapeutics
- 10
CRNXCrinetics Pharmaceuticals to Report Second Quarter 2026 Financial Results on August 4, 2026 | Crinetics
Source: Crinetics Pharmaceuticals
- 11
SRPTSarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Source: Sarepta Therapeutics
- 12
SRPTSarepta Announces FDA Acceptance of sNDAs for AMONDYS 45® and VYONDYS 53®
Source: Sarepta Therapeutics
- 13
- 14
REGNRegeneron to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call and Webcast
Source: Regeneron Pharmaceuticals
- 15
- 16
TSHATaysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
Source: Taysha Gene Therapies
- 17
PASGPassage Bio and Remix Therapeutics Announce Merger Agreement
Source: Passage Bio
- 18
TSHATaysha Gene Therapies Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Source: Taysha Gene Therapies
- 19
- 20
Companies in Gene Therapy
44 companies tagged with Gene Therapy.
Frequently Asked Questions
What does the Gene Therapy sector include?
Gene Therapy includes companies delivering genetic material to correct, replace, silence, or modulate disease-driving biology. This sector page is useful for following businesses exposed to AAV, lentiviral, non-viral, or editing-enabled approaches across rare and broader diseases.
How many companies are currently tagged with Gene Therapy?
44 companies are currently grouped under Gene Therapy on BioPharmSignal.
Which companies are most visible in the Gene Therapy group right now?
FDMT, ABEO, ADVM, AMGN are among the companies currently shown on this sector page.
How can I watch news for Gene Therapy?
Use the Watch button on this page to subscribe to Gene Therapy headlines and related company updates through your BioPharmSignal saved filters.
What kinds of updates usually appear for Gene Therapy?
The livefeed typically surfaces company press releases, clinical readouts, FDA and regulatory updates, partnerships, financings, and commercialization developments tied to companies in Gene Therapy.